About
Chronic conditions like cancer and endometriosis remain difficult to diagnose accurately due to the limitations of current imaging tools. Cancer is the most misdiagnosed of the 'big three' conditions, and 75% of endometriosis patients receive an incorrect diagnosis and are forced to undergo diagnostic surgery. While MRI and PET-CT often miss small findings, ultrasound is highly operator-dependent and inconsistent, leaving a critical gap in the early and reliable detection of disease.
Revealan™, our robotic ultrasound imaging platform, seamlessly integrates with any off-the-shelf ultrasound device to enable operator-agnostic, automated, AI-enabled, high-resolution 3D imaging. The robotic scan output is a series of standardized medical images with a density 10 times higher than that of an MRI. With Revealan™, we allow early detection and reliable follow-ups of small findings. Revealan™ is optimizing ultrasound for better patient outcomes.
Funding history · 2 rounds · $2.5M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was EndoCure founded?
- EndoCure was founded in November 2023.
- What is EndoCure's primary product?
- EndoCure's primary product is Revealan™, a robotic ultrasound imaging platform.
- What is the purpose of EndoCure's Revealan™ platform?
- Revealan™ transforms off-the-shelf ultrasound devices into AI-enabled, high-resolution 3D imaging tools for early detection and reliable follow-ups of small findings in chronic conditions like cancer and endometriosis.
- What was EndoCure's most recent funding round?
- In October 2025, EndoCure completed a Pre-Seed funding round, raising $500,000 from IL Investors Forum.
- What was EndoCure's first recorded funding round?
- In May 2024, EndoCure secured $400,000 in a Pre-Seed round with participation from MassChallenge Israel and Teuza.
- What is EndoCure's total amount raised in USD?
- According to startupim data, EndoCure has raised a total of $2,550,000 USD.
- How many grants has EndoCure received from the IIA?
- EndoCure has received four grants from the IIA, totaling $1,650,000, between June 2023 and December 2024.
- What was a notable achievement for EndoCure in November 2023?
- In November 2023, EndoCure was selected as a TOP12 finalist at the MEDICA STARTUP COMPETITION, out of 280 submissions.
- What is the current employee count for EndoCure?
- EndoCure currently has 5 employees.